General Neurology
Click on the sign to list the poster and platform presentations by year. Then click on the link to view that presentation.
2023
- Cognitive function remains associated with global functional impairment in profound dementia due to Alzheimer's disease and dementia with Lewy bodies.
American Academy of Neurology (AAN)
75th Annual Meeting in Boston, Mass. (April 22-28, 2023)
International Neuropsychological Society (INS)
51st Annual Meeting in San Diego, Calif. (Feb. 1-4, 2023)
2022
- Gender discrepancies in neurologist compensation.
- Impaired large fiber sensory exam with normal NCS.
[Oral Presentation]
American Academy of Neurology (AAN)
74th Annual Meeting in Seattle, Wash. (April 2-7, 2022)
Texas Scottish Rite Hospital for Children
44th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 24-25, 2022)
2021
- U.S. POINTER: Lessons learned about delivery of a multi-domain lifestyle intervention during the COVID-19 pandemic.
- Effects of narcolepsy during pregnancy on adverse maternal-fetal outcomes.
2021 Alzheimer's Association International Conference (AAIC)
Virtual Meeting (July 26-30, 2021)
Baylor College of Medicine (BCM)
4th Annual Center of Excellence in Health Equity, Training and Research Summer Research Summit in Houston, Texas (May 20, 2021)
<2020
- Neurosarcoidosis related vision loss mimicking idiopathic intracranial hypertension.
- US-POINTER (USA).
[Platform Presentation]
- Spanish/cross-cultural fellowship in neuropsychology: A response to the needs of the Houston Hispanic community.
- CCACTUS - Cross-cultural consortium on aging and cognition in Texas, U.S.: The development of a neuropsychology data repository.
- When Occam's razor fails: A McArdle disease diagnosis following idiopathic transverse myelitis.
- A case of hepatocellular carcinoma presenting with myasthenia gravis.
- The potential role of estrogen in moderating symptom severity in women with RYR1-related myopathy.
- Substantia nigra hyperintensities leads to diagnosis of Leber's hereditary optic neuropathy.
- Disseminated mycobacterium avium-intracellulare presenting with multiple cranial neuropathies.
- Eculizumab in refractory myasthenic crisis.
- Predictors of atypical antipsychotic treatment in an AD clinical population.
- Ataxia: The first sign of breast cancer.
- Chronic endurance exercise training in a mouse model of myotonic dystrophy type 1.
- Oculomotor and masticator muscle enhancement in a case of multiple cranial nerve palsies and internuclear ophthalmoplegia associated with herpes simplex virus infection.
- Comparing two 123I-Ioflupane SPECT processing methods for determination of basal ganglia volumes in patients with parkinsonian-like features.
- A rare heteroplasmic tRNALeu(CUN) mutation presenting with refractory seizures and myopathy.
- Rationale for establishing a Myotonic Dystrophy Multidisciplinary Clinic.
[Previously Presented]
- Headache and cutaneous allodynia in older adults without cognitive impairment.
[Previously Presented]
- Association between overall and mentholated cigarette smoking with headache: Results from the National Health and Nutrition Examination Survey 1999-2004.
[Previously Presented]
- Headache and cutaneous allodynia in older adults without cognitive impairment.
- Association between overall and mentholated cigarette smoking with headache: Results from the National Health and Nutrition Examination Survey 1999-2004.
- Rationale for establishing a Myotonic Dystrophy Multidisciplinary Clinic.
- Atypical presentation of inclusion body myositis.
- Oxidative metabolism during forearm exercise in McArdle disease.
- A distinctive delayed form of exertional rhabdomyolysis.
[Platform Presentation]
- Not PFK deficiency.
- A distinctive delayed form of exertional rhabdomyolysis.
- Fixed weakness in McArdle disease.
- Exercise intolerance with congenital anomalies.
- Rare family with autosomal dominant oculopharyngeal muscular dystrophy showing anticipation.
- Glycogen breakdown is preserved during exercise in severe muscle phosphorylase b kinase deficiency.
[Previously Presented]
- Glycogen breakdown is preserved during exercise.
- Not PFK deficiency.
[Oral Presentation]
- Progressive weakness in a patient with static encephalopathy and colpocephaly.
- Deep brain stimulation of the subthalamic nucleus on Parkinson's disease: Effects on quality of life.
[Previously Presented]
- Long term safety of deep brain stimulation for the treatment of Parkinson's disease.
- Characteristics of Parkinson's disease in patients with childhood-onset essential tremor.
[Previously Presented]
- Gait and balance assessment in parkinsonian disorders.
- Globus pallidus deep brain stimulation in dystonia.
- Tetrabenazine: Does prior history of depression preclude this drug as a treatment option?
- Medications associated with the onset of tardive dyskinesia.
- Predictors of battery life for the Activa® Soletra 7426 neurostimulator.
- Characteristics of Parkinson's disease in patients with childhood-onset essential tremor.
- Tetrabenazine, a monoamine depleter, effective in the treatment of Tourette syndrome.
- Tetrabenazine: Effective treatment for tardive dyskinesia.
- Young-onset versus late-onset Parkinson's disease: Clinical features and disease progression.
- Long-term prognosis of psychogenic movement disorders.
- Psychogenic dystonia: Clinical characteristics and long-term progression.
- Safety and efficacy of tetrabenazine in childhood hyperkinetic movement disorders.
- Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
- Essential tremor in children.
- Psychogenic tremor: Long-term outcome.
- The efficacy and safety of fluphenazine in patients with Tourette syndrome.
- Treatment of hypophonia with collagen vocal fold augmentation in patients with parkinsonism.
- Age-related tolerability of tetrabenazine.
- Tetrabenazine in the treatment of Tourette syndrome.
- Evaluating factors that can influence spirography ratings in patients with essential tremor.
- Predictors of response to bilateral subthalamic nucleus stimulation for Parkinson's disease.
- The prevalence of restless legs syndrome in patients with Parkinson's disease.
- Exploring the relationship between Parkinson's disease and restless legs syndrome.
- Olanzapine treatment for dopaminergic induced hallucinations.
- Daytime sleepiness in patients with Parkinson's disease.
- Unilateral thalamic deep brain stimulation for essential tremor and Parkinson's disease: Effects of stimulation on the non-target limb and rebound augmentation.
American Neurological Association (ANA)
145th Annual Meeting in Los Angeles, Calif. (Oct. 4-6, 2020)
2020 Alzheimer's Association International Conference (AAIC)
Virtual Meeting (July 27-31, 2020)
Baylor College of Medicine (BCM)
2nd Annual Center of Excellence in Health Equity, Training and Research Summer Research Summit in Houston, Texas (June 18, 2019)
American Academy of Neurology (AAN)
71st Annual Meeting in Philadelphia, Penn. (May 4-10, 2019)
North American Neuro-Ophthalmology Society (NANOS)
45th Annual Meeting in Las Vegas, Nev. (March 16-21, 2019)
American Neurological Association (ANA)
143rd Annual Meeting in Atlanta, Ga. (Oct. 21-23, 2018)
American Academy of Neurology (AAN)
70th Annual Meeting in Los Angeles, Calif. (April 21-27, 2018)
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
64th Annual Meeting in Phoenix, Ariz. (Sept. 13-16, 2017)
2017 Alzheimer's Association International Conference (AAIC)
London, United Kingdom (July 15-20, 2017)
Society of General Internal Medicine (SGIM)
2017 Southern Regional Meeting in New Orleans, La. (Feb. 10-12, 2017)
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
63rd Annual Meeting in New Orleans, La. (Sept. 14-17, 2016)
Association of University Radiologists (AUR)
64th Annual Meeting in San Diego, Calif. (March 29 - April 1, 2016)
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
62nd Annual Meeting in Honolulu, Hawaii (Oct. 28-31, 2015)
University of Kentucky
2015 Clinical & Translational Neuroscience Exposition in Lexington, Ky. (June 26, 2015)
American Headache Society
57th Annual Scientific Meeting in Washington, DC (June 18-21, 2015)
International Myotonic Dystrophy Consortium (IDMC)
10th Meeting in Paris, France (June 8-10, 2015)
American Academy of Neurology (AAN)
67th Annual Meeting in Washington, DC (April 18-25, 2015)
American Academy of Neurology (AAN)
66th Annual Meeting in Philadelphia, Penn. (April 26 - May 3, 2014)
Texas Scottish Rite Hospital for Children
36th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 13-14, 2014)
American Academy of Neurology (AAN)
65th Annual Meeting in San Diego, Calif. (March 16-23, 2013)
Texas Scottish Rite Hospital for Children
35th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 14-15, 2013)
Texas Scottish Rite Hospital for Children
34th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 23-24, 2012)
Movement Disorder Society (MDS)
11th International Congress of Parkinson's Disease and Movement Disorders in Istanbul, Turkey (June 3-7, 2007)
Movement Disorder Society (MDS)
10th International Congress of Parkinson's Disease and Movement Disorders in Kyoto, Japan (Oct. 30 - Nov. 2, 2006)
American Neurological Association (ANA)
131st Annual Meeting in Chicago, Ill. (Oct. 8-11, 2006)
American Academy of Neurology (AAN)
58th Annual Meeting in San Diego, Calif. (April 1-8, 2006)
American Academy of Neurology (AAN)
57th Annual Meeting in Miami Beach, Fla. (April 9-16, 2005)
Movement Disorder Society (MDS)
9th International Congress of Parkinson's Disease and Movement Disorders in New Orleans, La. (March 5-8, 2005)
American Neurological Association (ANA)
129th Annual Meeting in Toronto, Canada (Oct. 4-5, 2004)
Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders
18th Annual Symposium in Toronto, Canada (Oct. 3, 2004)
Movement Disorder Society (MDS)
8th International Congress of Parkinson's Disease and Movement Disorders in Rome, Italy (June 13-17, 2004)
American Academy of Neurology (AAN)
56th Annual Meeting in San Francisco, Calif. (April 24 - May 1, 2004)
American Society for Experimental NeuroTherapeutics (ASENT)
6th Annual Meeting in Bethesda, Md. (March 11-13, 2004)
American Academy of Neurology (AAN)
55th Annual Meeting in Honolulu, Hawaii (March 29 - April 5, 2003)
Movement Disorder Society (MDS)
7th International Congress of Parkinson's Disease and Movement Disorders in Miami, Fla. (Nov. 10-14, 2002)
American Headache Society
44th Annual Scientific Meeting in Seattle, Wash. (June 21-23, 2002)
Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins
International Conference in Hannover, Germany (June 8, 2002)
American Academy of Neurology (AAN)
53rd Annual Meeting in Philadelphia, Penn. (May 5-11, 2001)
Movement Disorder Society (MDS)
6th International Congress of Parkinson's Disease and Movement Disorders in Barcelona, Spain (June 11-15, 2000)
American Academy of Neurology (AAN)
52nd Annual Meeting in San Diego, Calif. (April 29 - May 6, 2000)